Possible mechanisms of Pseudomonas aeruginosa-associated lung disease

International Journal of Medical Microbiology

Volumn 306, Issue 1, 2016, Pages 20-28

  Gonçalves de Albuquerque, Cassiano Felippe ^a   Silva, Adriana Ribeiro ^a   Burth, Patrícia ^b   Rocco, Patricia Rieken Macêdo ^c   Castro Faria, Mauro Velho ^d   Castro Faria Neto, Hugo Caire ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

Author keywords

Inflammation; Lung injury; Pseudomonas aeruginosa

Indexed keywords

MATRIX METALLOPROTEINASE; TOLL LIKE RECEPTOR; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; BIOFILM; HOST CELL; HUMAN; IMMUNE EVASION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LUNG DISEASE; LUNG INJURY; NONHUMAN; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SHORT SURVEY; BACTERIAL PNEUMONIA; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; QUORUM SENSING;

GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INFLAMMATION; LUNG INJURY; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

EID: 84953207395     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.11.001     Document Type: Short Survey

References (127)

1. Alhede M., Bjarnsholt T., Jensen P.O., Phipps R.K., Moser C., Christophersen L., Christensen L.D., van Gennip M., Parsek M., Hoiby N., Rasmussen T.B., Givskov M. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 2009, 155:3500-3508.
2. Ashish A., Paterson S., Mowat E., Fothergill J.L., Walshaw M.J., Winstanley C. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis. J. Cyst. Fibros. 2013, 12:790-793.
3. Bala A., Chhibber S., Harjai K. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa. Int. J. Med. Microbiol. 2014, 304:1199-1208.
4. Benmohamed F., Medina M., Wu Y.Z., Maschalidi S., Jouvion G., Guillemot L., Chignard M., Manoury B., Touqui L. Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection. PLOS ONE 2014, 9:e90466.
5. Blackwood L.L., Stone R.M., Iglewski B.H., Pennington J.E. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection. Infect. Immun. 1983, 39:198-201.
6. Broquet A., Roquilly A., Jacqueline C., Potel G., Caillon J., Asehnoune K. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model. Crit. Care Med. 2014, 42:e441-e450.
7. Campodonico V.L., Gadjeva M., Paradis-Bleau C., Uluer A., Pier G.B. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol. Med. 2008, 14:120-133.
8. Carles M., Wagener B.M., Lafargue M., Roux J., Iles K., Liu D., Rodriguez C.A., Anjum N., Zmijewski J., Ricci J.E., Pittet J.F. Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice. Anesthesiology 2014, 120:1450-1462.
9. Chai W., Zhang J., Duan Y., Pan D., Liu W., Li Y., Yan X., Chen B. Pseudomonas pyocyanin stimulates IL-8 expression through MAPK and NF-kappaB pathways in differentiated U937 cells. BMC Microbiol. 2014, 14:26.
10. Chen H.I., Kao S.J., Hsu Y.H. Pathophysiological mechanism of lung injury in patients with leptospirosis. Pathology 2007, 39:339-344.
11. Christen U., von Herrath M.G. Infections and autoimmunity - good or bad?. J. Immunol. 2005, 174:7481-7486.
12. Chung J.W., Piao Z.H., Yoon S.R., Kim M.S., Jeong M., Lee S.H., Min J.K., Kim J.W., Cho Y.H., Kim J.C., Ahn J.K., Kim K.E., Choi I. Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis. PLoS Pathog. 2009, 5:e1000561.
13. Chung J.C., Becq J., Fraser L., Schulz-Trieglaff O., Bond N.J., Foweraker J., Bruce K.D., Smith G.P., Welch M. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J. Bacteriol. 2012, 194:4857-4866.
14. Ciornei C.D., Novikov A., Beloin C., Fitting C., Caroff M., Ghigo J.M., Cavaillon J.M., Adib-Conquy M. Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes. Innate Immun. 2010, 16:288-301.
15. Coggan K.A., Wolfgang M.C. Global regulatory pathways and cross-talk control Pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr. Issues Mol. Biol. 2012, 14:47-70.
16. Cohen T.S., Gray Lawrence G., Margulies S.S. Cultured alveolar epithelial cells from septic rats mimic in vivo septic lung. PLoS ONE 2010, 5:e11322.
17. de Kievit T.R., Iglewski B.H. Bacterial quorum sensing in pathogenic relationships. Infect. Immun. 2000, 68:4839-4849.
18. De Kievit T.R., Gillis R., Marx S., Brown C., Iglewski B.H. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol. 2001, 67:1865-1873.
19. Diaz M.H., Shaver C.M., King J.D., Musunuri S., Kazzaz J.A., Hauser A.R. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 2008, 76:4414-4421.
20. Dubin P.J., Martz A., Eisenstatt J.R., Fox M.D., Logar A., Kolls J.K. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 2012, 80:398-409.
21. Epelman S., Bruno T.F., Neely G.G., Woods D.E., Mody C.H. Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines. Infect. Immun. 2000, 68:4811-4814.
22. Faure K., Sawa T., Ajayi T., Fujimoto J., Moriyama K., Shime N., Wiener-Kronish J.P. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 2004, 5:1.
23. Faure E., Mear J.B., Faure K., Normand S., Couturier-Maillard A., Grandjean T., Balloy V., Ryffel B., Dessein R., Chignard M., Uyttenhove C., Guery B., Gosset P., Chamaillard M., Kipnis E. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am. J. Respir. Crit. Care Med. 2014, 189:799-811.
24. Finck-Barbancon V., Goranson J., Zhu L., Sawa T., Wiener-Kronish J.P., Fleiszig S.M., Wu C., Mende-Mueller L., Frank D.W. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 1997, 25:547-557.
25. Finlay B.B., McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124:767-782.
26. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., Halaas O., Akira S., Skjak-Braek G., Golenbock D.T., Espevik T. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 2002, 277:35489-35495.
27. Fothergill J.L., Neill D.R., Loman N., Winstanley C., Kadioglu A. Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs. Nat. Commun. 2014, 5:4780.
28. Frank D.W. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol. Microbiol. 1997, 26:621-629.
29. Frank S.A., Schmid-Hempel P. Mechanisms of pathogenesis and the evolution of parasite virulence. J. Evol. Biol. 2008, 21:396-404.
30. Ganter M.T., Roux J., Su G., Lynch S.V., Deutschman C.S., Weiss Y.G., Christiaans S.C., Myazawa B., Kipnis E., Wiener-Kronish J.P., Howard M., Pittet J.F. Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. Am. J. Respir. Cell Mol. Biol. 2009, 40:108-118.
31. Glucksam-Galnoy Y., Sananes R., Silberstein N., Krief P., Kravchenko V.V., Meijler M.M., Zor T. The bacterial quorum-sensing signal molecule N-3-oxo-dodecanoyl-l-homoserine lactone reciprocally modulates pro- and anti-inflammatory cytokines in activated macrophages. J. Immunol. 2013, 191:337-344.
32. Goncalves-de-Albuquerque C.F., Burth P., Silva A.R., de Moraes I.M., de Jesus Oliveira F.M., Santelli R.E., Freire A.S., Bozza P.T., Younes-Ibrahim M., de Castro-Faria-Neto H.C., de Castro-Faria M.V. Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production. J. Inflamm. (Lond.) 2013, 10:34.
33. Goncalves-de-Albuquerque C.F., Burth P., Silva A.R., de Moraes I.M., Oliveira F.M., Santelli R.E., Freire A.S., de Lima G.S., da Silva E.D., da Silva C.I., Morandi V., Bozza P.T., Younes-Ibrahim M., de Castro Faria Neto H.C., de Castro Faria M.V. Murine lung injury caused by Leptospira interrogans glycolipoprotein, a specific Na/K-ATPase inhibitor. Respir. Res. 2014, 15:93.
34. Guillemot L., Medina M., Pernet E., Leduc D., Chignard M., Touqui L., Wu Y. Cytosolic phospholipase A2alpha enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6. Biochimie 2014, 107(Pt. A):95-104.
35. Gupta R.K., Chhibber S., Harjai K. Quorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa. Immunobiology 2013, 218:181-185.
36. Hansch G.M., Prior B., Brenner-Weiss G., Obst U., Overhage J. The Pseudomonas quinolone signal (PQS) stimulates chemotaxis of polymorphonuclear neutrophils. J. Appl. Biomater. Funct. Mater. 2014, 12:21-26.
37. Harder J., Meyer-Hoffert U., Teran L.M., Schwichtenberg L., Bartels J., Maune S., Schroder J.M. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 2000, 22:714-721.
38. Hartl D., Gaggar A., Bruscia E., Hector A., Marcos V., Jung A., Greene C., McElvaney G., Mall M., Doring G. Innate immunity in cystic fibrosis lung disease. J. Cyst. Fibros. 2012, 11:363-382.
39. Hentzer M., Wu H., Andersen J.B., Riedel K., Rasmussen T.B., Bagge N., Kumar N., Schembri M.A., Song Z., Kristoffersen P., Manefield M., Costerton J.W., Molin S., Eberl L., Steinberg P., Kjelleberg S., Hoiby N., Givskov M. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003, 22:3803-3815.
40. Hippenstiel S., Opitz B., Schmeck B., Suttorp N. Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Respir. Res. 2006, 7:97.
41. Hoiby N., Krogh Johansen H., Moser C., Song Z., Ciofu O., Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 2001, 3:23-35.
42. Honda E., Homma J.Y., Abe C., Tanamoto K., Noda H., Yanagawa R. Effects of the common protective antigen (OEP) and toxoids of protease and elastase from Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink. Zentralbl. Bakteriol. Orig. A 1977, 237:297-309.
43. Hornef M.W., Wick M.J., Rhen M., Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 2002, 3:1033-1040.
44. Jensen P.O., Bjarnsholt T., Phipps R., Rasmussen T.B., Calum H., Christoffersen L., Moser C., Williams P., Pressler T., Givskov M., Hoiby N. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 2007, 153:1329-1338.
45. Jensen P.O., Givskov M., Bjarnsholt T., Moser C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 2010, 59:292-305.
46. Jimenez P.N., Koch G., Thompson J.A., Xavier K.B., Cool R.H., Quax W.J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 2012, 76:46-65.
47. Joseph T., Look D., Ferkol T. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L471-L479.
48. Junkins R.D., Shen A., Rosen K., McCormick C., Lin T.J. Autophagy enhances bacterial clearance during P. aeruginosa lung infection. PLOS ONE 2013, 8:e72263.
49. Kang C.I., Kim S.H., Kim H.B., Park S.W., Choe Y.J., Oh M.D., Kim E.C., Choe K.W. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin. Infect. Dis. 2003, 37:745-751.
50. Kazmierczak B.I., Engel J.N. Pseudomonas aeruginosa ExoT acts in vivo as a GTPase-activating protein for RhoA, Rac1, and Cdc42. Infect. Immun. 2002, 70:2198-2205.
51. Kida Y., Shimizu T., Kuwano K. Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice. Infect. Immun. 2011, 79:211-219.
52. Kim Y.J., Paek S.H., Jin S., Park B.S., Ha U.H. A novel Pseudomonas aeruginosa-derived effector cooperates with flagella to mediate the upregulation of interleukin 8 in human epithelial cells. Microb. Pathog. 2014, 66:24-28.
53. Koller B., Kappler M., Latzin P., Gaggar A., Schreiner M., Takyar S., Kormann M., Kabesch M., Roos D., Griese M., Hartl D. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J. Immunol. 2008, 181:2753-2763.
54. Kube D., Sontich U., Fletcher D., Davis P.B. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L493-L502.
55. LaBauve A.E., Wargo M.J. Detection of host-derived sphingosine by Pseudomonas aeruginosa is important for survival in the murine lung. PLoS Pathog. 2014, 10:e1003889.
56. Ladwig G.P., Robson M.C., Liu R., Kuhn M.A., Muir D.F., Schultz G.S. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen. 2002, 10:26-37.
57. Lavoie E.G., Wangdi T., Kazmierczak B.I. Innate immune responses to Pseudomonas aeruginosa infection. Microbes Infect. 2011, 13:1133-1145.
58. Lee J., Wu J., Deng Y., Wang J., Wang C., Wang J., Chang C., Dong Y., Williams P., Zhang L.H. A cell-cell communication signal integrates quorum sensing and stress response. Nat. Chem. Biol. 2013, 9:339-343.
59. Legendre C., Reen F.J., Mooij M.J., McGlacken G.P., Adams C., O'Gara F. Pseudomonas aeruginosa alkyl quinolones repress hypoxia-inducible factor 1 (HIF-1) signaling through HIF-1alpha degradation. Infect. Immun. 2012, 80:3985-3992.
60. Lovewell R.R., Collins R.M., Acker J.L., O'Toole G.A., Wargo M.J., Berwin B. Step-wise loss of bacterial flagellar torsion confers progressive phagocytic evasion. PLoS Pathog. 2011, 7:e1002253.
61. Lovewell R.R., Hayes S.M., O'Toole G.A., Berwin B. Pseudomonas aeruginosa flagellar motility activates the phagocyte PI3K/Akt pathway to induce phagocytic engulfment. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L698-L707.
62. Lovewell R.R., Patankar Y.R., Berwin B. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L591-L603.
63. Luzar M.A., Thomassen M.J., Montie T.C. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 1985, 50:577-582.
64. Mahenthiralingam E., Campbell M.E., Speert D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 1994, 62:596-605.
65. Markussen T., Marvig R.L., Gomez-Lozano M., Aanaes K., Burleigh A.E., Hoiby N., Johansen H.K., Molin S., Jelsbak L. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 2014, 5:e01592-14.
66. Martel G., Roussel L., Rousseau S. The protein kinases TPL2 and EGFR contribute to ERK1/ERK2 hyperactivation in CFTRDeltaF508-expressing airway epithelial cells exposed to Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 2013, 441:689-692.
67. Mathee K., Narasimhan G., Valdes C., Qiu X., Matewish J.M., Koehrsen M., Rokas A., Yandava C.N., Engels R., Zeng E., Olavarietta R., Doud M., Smith R.S., Montgomery P., White J.R., Godfrey P.A., Kodira C., Birren B., Galagan J.E., Lory S. Dynamics of Pseudomonas aeruginosa genome evolution. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3100-3105.
68. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu. Rev. Pathol. 2011, 6:147-163.
69. Matthay M.A., Ware L.B., Zimmerman G.A. The acute respiratory distress syndrome. J. Clin. Investig. 2012, 122:2731-2740.
70. Mayer-Hamblett N., Ramsey B.W., Kulasekara H.D., Wolter D.J., Houston L.S., Pope C.E., Kulasekara B.R., Armbruster C.R., Burns J.L., Retsch-Bogart G., Rosenfeld M., Gibson R.L., Miller S.I., Khan U., Hoffman L.R. Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. Clin. Infect. Dis. 2014, 59:624-631.
71. McFarland K.A., Dolben E.L., LeRoux M., Kambara T.K., Ramsey K.M., Kirkpatrick R.L., Mougous J.D., Hogan D.A., Dove S.L. A self-lysis pathway that enhances the virulence of a pathogenic bacterium. Proc. Natl. Acad. Sci. U. S. A. 2015, 112(27):8433-8438.
72. McIsaac S.M., Stadnyk A.W., Lin T.J. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. J. Leukoc. Biol. 2012, 92:977-985.
73. Miao E.A., Ernst R.K., Dors M., Mao D.P., Aderem A. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2562-2567.
74. Mijares L.A., Wangdi T., Sokol C., Homer R., Medzhitov R., Kazmierczak B.I. Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J. Immunol. 2011, 186:7080-7088.
75. Miller S.I., Ernst R.K., Bader M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3:36-46. 10.1038/nrmicro1068.
76. Mittal R., Sharma S., Chhibber S., Harjai K. Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J. Microbiol. Immunol. Infect. 2006, 39:302-309.
77. Morris A.E., Liggitt H.D., Hawn T.R., Skerrett S.J. Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1112-L1119.
78. Mowat E., Paterson S., Fothergill J.L., Wright E.A., Ledson M.J., Walshaw M.J., Brockhurst M.A., Winstanley C. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 2011, 183:1674-1679.
79. Muh U., Schuster M., Heim R., Singh A., Olson E.R., Greenberg E.P. Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob. Agents Chemother. 2006, 50:3674-3679.
80. Nakagami G., Minematsu T., Morohoshi T., Yamane T., Kanazawa T., Huang L., Asada M., Nagase T., Ikeda S.I., Ikeda T., Sanada H. Pseudomonas aeruginosa quorum-sensing signaling molecule N-3-oxododecanoyl homoserine lactone induces matrix metalloproteinase 9 expression via the AP1 pathway in rat fibroblasts. Biosci. Biotechnol. Biochem. 2015, 1-5.
81. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 2013, 13:349-361.
82. Nieuwenhuizen L., de Groot P.G., Grutters J.C., Biesma D.H. A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia. Eur. J. Haematol. 2009, 82:413-425.
83. Opitz B., van Laak V., Eitel J., Suttorp N. Innate immune recognition in infectious and noninfectious diseases of the lung. Am. J. Respir. Crit. Care Med. 2010, 181:1294-1309.
84. Pamukcu A., Bush A., Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr. Pulmonol. 1995, 19:10-15.
85. Park S.J., Kim S.K., So Y.I., Park H.Y., Li X.H., Yeom D.H., Lee M.N., Lee B.L., Lee J.H. Protease IV, a quorum sensing-dependent protease of Pseudomonas aeruginosa modulates insect innate immunity. Mol. Microbiol. 2014, 94:1298-1314.
86. Patankar Y.R., Lovewell R.R., Poynter M.E., Jyot J., Kazmierczak B.I., Berwin B. Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa. Infect. Immun. 2013, 81:2043-2052.
87. Pene F., Grimaldi D., Zuber B., Sauneuf B., Rousseau C., El Hachem C., Martin C., Belaidouni N., Balloy V., Mira J.P., Chiche J.D. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction. J. Infect. Dis. 2012, 206:932-942.
88. Phillips R.M., Six D.A., Dennis E.A., Ghosh P. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 2003, 278:41326-41332.
89. Pierrakos C., Karanikolas M., Scolletta S., Karamouzos K., Velissaris D. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J. Clin. Med. Res. 2012, 4:7-16.
90. Plotkowski M.C., Brandao B.A., de Assis M.C., Feliciano L.F., Raymond B., Freitas C., Saliba A.M., Zahm J.M., Touqui L., Bozza P.T. Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb. Pathog. 2008, 45:30-37.
91. Qi J., Li L., Du Y., Wang S., Wang J., Luo Y., Che J., Lu J., Liu H., Hu G., Li J., Gong Y., Wang G., Hu M., Shiganyan, Liu Y. The identification, typing, and antimicrobial susceptibility of Pseudomonas aeruginosa isolated from mink with hemorrhagic pneumonia. Vet. Microbiol. 2014, 170:456-461.
92. Rada B., Leto T.L. Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections. Trends Microbiol. 2013, 21:73-81.
93. Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence 2014, 5:213-218.
94. Ramphal R., Balloy V., Jyot J., Verma A., Si-Tahar M., Chignard M. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 2008, 181:586-592.
95. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012, 307:2526-2533.
96. Raoust E., Balloy V., Garcia-Verdugo I., Touqui L., Ramphal R., Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS ONE 2009, 4:e7259.
97. Redpath S., Ghazal P., Gascoigne N.R. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 2001, 9:86-92.
98. Rejman J., Di Gioia S., Bragonzi A., Conese M. Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection. Hum. Gene Ther. 2007, 18:642-652.
99. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 2009, 136:e30.
100. Rosenfeld M., Ramsey B.W., Gibson R.L. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr. Opin. Pulm. Med. 2003, 9:492-497.
101. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., Stern E.J., Hudson L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353:1685-1693.
102. Sadikot R.T., Blackwell T.S., Christman J.W., Prince A.S. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171:1209-1223.
103. Sawa T., Corry D.B., Gropper M.A., Ohara M., Kurahashi K., Wiener-Kronish J.P. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 1997, 159:2858-2866.
104. Schultz M.J., Rijneveld A.W., Florquin S., Edwards C.K., Dinarello C.A., van der Poll T. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L285-L290.
105. Schuster M., Greenberg E.P. A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int. J. Med. Microbiol. 2006, 296:73-81.
106. Shen Z., Fang L., Zhao L., Lei H. Beta-defensin 2 ameliorates lung injury caused by Pseudomonas infection and regulates proinflammatory and anti-inflammatory cytokines in rat. Int. J. Mol. Sci. 2014, 15:13372-13387.
107. Shiner E.K., Terentyev D., Bryan A., Sennoune S., Martinez-Zaguilan R., Li G., Gyorke S., Williams S.C., Rumbaugh K.P. Pseudomonas aeruginosa autoinducer modulates host cell responses through calcium signalling. Cell. Microbiol. 2006, 8:1601-1610.
108. Skerrett S.J., Wilson C.B., Liggitt H.D., Hajjar A.M. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L312-L322.
109. Soini Y. Claudins in lung diseases. Respir. Res. 2011, 12:70.
110. Sorci G., Cornet S., Faivre B. Immune evasion, immunopathology and the regulation of the immune system. Pathogens 2013, 2:71-91.
111. Southard R., Ghosh S., Hilliard J., Davis C., Mazuski C., Walton A., Hotchkiss R. Pulmonary contusion is associated with toll-like receptor 4 upregulation and decreased susceptibility to pseudomonas pneumonia in a mouse model. Shock 2012, 37:629-633.
112. Stevens T.C., Ochoa C.D., Morrow K.A., Robson M.J., Prasain N., Zhou C., Alvarez D.F., Frank D.W., Balczon R., Stevens T. The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L915-L924.
113. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., Gordon S. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 2005, 23:901-944.
114. Traidej M., Marquart M.E., Caballero A.R., Thibodeaux B.A., O'Callaghan R.J. Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation. J. Biol. Chem. 2003, 278:2549-2553.
115. Van Gennip M., Christensen L.D., Alhede M., Phipps R., Jensen P.O., Christophersen L., Pamp S.J., Moser C., Mikkelsen P.J., Koh A.Y., Tolker-Nielsen T., Pier G.B., Hoiby N., Givskov M., Bjarnsholt T. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 2009, 117:537-546.
116. Veesenmeyer J.L., Hauser A.R., Lisboa T., Rello J. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit. Care Med. 2009, 37:1777-1786.
117. Venturi V. Regulation of quorum sensing in Pseudomonas. FEMS Microbiol. Rev. 2006, 30:274-291.
118. Williams P., Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr. Opin. Microbiol. 2009, 12:182-191.
119. Williams B.J., Dehnbostel J., Blackwell T.S. Pseudomonas aeruginosa: host defence in lung diseases. Respirology 2010, 15:1037-1056.
120. Williams D., Evans B., Haldenby S., Walshaw M.J., Brockhurst M.A., Winstanley C., Paterson S. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am. J. Respir. Crit. Care Med. 2015, 191:775-785.
121. Wolbeling F., Munder A., Kerber-Momot T., Neumann D., Hennig C., Hansen G., Tummler B., Baumann U. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection. Immunobiology 2011, 216:901-908.
122. Wolf P., Elsasser-Beile U. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. Int. J. Med. Microbiol. 2009, 299:161-176.
123. Workentine M.L., Sibley C.D., Glezerson B., Purighalla S., Norgaard-Gron J.C., Parkins M.D., Rabin H.R., Surette M.G. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLOS ONE 2013, 8:e60225.
124. Xu X., Shao B., Wang R., Zhou S., Tang Z., Lu W., Xiong S. Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs. Int. J. Clin. Exp. Med. 2014, 7:809-816.
125. Yoo D.G., Winn M., Pang L., Moskowitz S.M., Malech H.L., Leto T.L., Rada B. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation. J. Immunol. 2014, 192:4728-4738.
126. Young D., Hussell T., Dougan G. Chronic bacterial infections: living with unwanted guests. Nat. Immunol. 2002, 3:1026-1032.
127. Zimmermann S., Wagner C., Muller W., Brenner-Weiss G., Hug F., Prior B., Obst U., Hansch G.M. Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone. Infect. Immun. 2006, 74:5687-5692.